CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-21 | Huang Michael Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-02-22 | Loose Christopher R. Chief Scientific Officer | Sale | −1,069 | $3.53 | $4K | 34,827 |
| 2022-02-22 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,542 | $3.53 | $5K | 8,927 |
| 2022-02-22 | LeBel Carl Chief Development Officer | Sale | −1,069 | $3.53 | $4K | 11,126 |
| 2022-02-22 | McCubbin Quentin Chief Manufacturing Officer | Sale | −1,584 | $3.53 | $6K | 22,771 |
| 2022-02-22 | Arnold Wendy S Chief People Officer | Sale | −1,326 | $3.53 | $5K | 11,824 |
| 2022-02-18 | Loose Christopher R. Chief Scientific Officer | Sale | −974 | $3.87 | $4K | 35,896 |
| 2022-02-18 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,404 | $3.88 | $5K | 10,469 |
| 2022-02-18 | LeBel Carl Chief Development Officer | Sale | −974 | $3.87 | $4K | 12,195 |
| 2022-02-18 | McCubbin Quentin Chief Manufacturing Officer | Sale | −1,411 | $3.87 | $5K | 24,355 |
| 2022-02-18 | Arnold Wendy S Chief People Officer | Sale | −1,209 | $3.87 | $5K | 13,150 |
| 2022-02-17 | Lucchino David L. President and CEO | Grant or award · Restricted Stock Unit | +300,000 | 300,000 | ||
| 2022-02-17 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,296 | $4.20 | $5K | 11,873 |
| 2022-02-17 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | ||
| 2022-02-17 | Loose Christopher R. Chief Scientific Officer | Sale | −900 | $4.19 | $4K | 36,870 |
| 2022-02-17 | Loose Christopher R. Chief Scientific Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | ||
| 2022-02-17 | LeBel Carl Chief Development Officer | Sale | −901 | $4.19 | $4K | 13,169 |
| 2022-02-17 | LeBel Carl Chief Development Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | ||
| 2022-02-17 | McCubbin Quentin Chief Manufacturing Officer | Sale | −1,303 | $4.20 | $5K | 25,766 |
| 2022-02-17 | McCubbin Quentin Chief Manufacturing Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 |
Page 20 of 23 · 441 trades